Trying to learn how to translate from the human translation examples.
From: Machine Translation
Suggest a better translation
Quality:
From professional translators, enterprises, web pages and freely available translation repositories.
बीपी पिक्चर english bp picture
् ् ् ् ् ् ्ी ् ्् ्् ् ् ् ्
Last Update: 2023-11-06
Usage Frequency: 1
Quality:
b p<0,0001
b p<0.0001
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
nærfingurliðir b p- gildi
pip jointsb p-value
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a p < 0,001 b p < 0,01
a p < 0.001 b p < 0.01
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
b p < 0,001 samanborið við etanercept
b p < 0.001 compared with etanercept
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
hr (95% ci)b p-gildi
hr (95% ci)b p-valuec
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
b: p = 0,002, enbrel vs. lyfleysu
b: p = 0.002, enbrel vs. placebo
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
b p < 0,05. c Á ekki við. d p < 0,001.
b p < 0.05. c not applicable. d p < 0.001.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
b p < 0,05 c tölulega marktækt (p < 0,05)
b p < 0.05 c nominally significant (p < 0.05)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
sjúklingar sem reyndu að draga úr/hætta upphaflegri meðferð, n (%)b p-gildi a
patients who attempted to reduce or discontinue baseline therapy, n (%)b p-value a
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a p < 0,001, etanercept samanborið við lyfleysu b p = 0,002, etanercept samanborið við lyfleysu
a p < 0.001, etanercept vs. placebo b p = 0.002, etanercept vs. placebo
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
b p-gildi fyrir tíma að versnun byggt á lagskiptri log-rank prófun c p-gidi voru ekki aðlöguð að margföldun
b p-value for time to deterioration based on stratified log-rank test c p-values were not adjusted for multiplicity
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a Ákvarðað út frá cox aðhverfulíkani b p-gildi fyrir samverkun milli upphafssérkenna og meðferðar, byggt á cox aðhverfulíkani c kalsíumgangalokar sem hægja á hjartsláttartíðni takmarkaðir við diltiazem, verapamil og bepridil
dronedarone better placebo better b p-value of interaction between baseline characteristics and treatment based on cox regression model c calcium antagonists with heart rate lowering effects restricted to diltiazem, verapamil and bepridil
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a p < 0,001; b p = 0,010; c p = 0,009; d p = 0,014
a p < 0.001; b p = 0.010; c p = 0.009; d p = 0.014
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
a gildin eru gefin upp fyrir giotrif á móti krabbameinslyfjameðferð, p-gildi samkvæmt aðhvarfsgreiningu b p-gildi fyrir tíma að versnun samkvæmt lagskiptu log-rank prófi
a values presented for giotrif vs. chemotherapy, p-value based on logistic regression b p-value for time to deterioration based on stratified log-rank test
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
a fengið með lagskiptri fjölþáttagreiningu (stratified proportional hazards model). b p-gildi er fengið með raðprófanaskrá (log-rank test), lagskiptri eftir fyrri viðhaldsmeðferð og meðferðarlotu; samsvarandi o’brien-fleming marktækni virknimarka (efficacy boundary significance level) er 0,0408.
a derived from a stratified proportional hazards model. b p-value is derived from a log-rank test stratified by prior maintenance therapy and line of therapy; the corresponding o’brien-fleming efficacy boundary significance level is 0.0408.
Last Update: 2017-04-26
Usage Frequency: 1
Quality: